The American Cancer Society has updated its screening recommendations, adding blood-based tests for colorectal cancer detection. This new guideline targets adults aged 45 and older who are at average risk but have either declined or completed traditional visual examinations and stool tests. The shift in recommendations aligns with alarming trends, as colorectal cancer cases have seen a significant increase in recent years.
Colorectal Cancer Statistics and Trends
A study published in April 2026 by the Canadian Medical Association Journal noted that colorectal cancer will constitute about 47% of all new cancer diagnoses in Canada. Projections suggest that 11% of Canadian men and 9% of women will be diagnosed with colorectal cancer by 2026. Furthermore, this disease is expected to account for 10% of cancer-related deaths among both genders.
Benefits of Blood-Based Screening
- Blood tests provide a simpler alternative to invasive procedures.
- Easier for patients, as it requires less preparation compared to a colonoscopy.
- No fasting or dietary restrictions are necessary.
Dr. Yoo-Joung Ko, a medical oncologist, emphasized the patient-friendly nature of blood-based tests, stating they are more manageable than traditional methods. Filomena Servidio-Italiano of the Colorectal Cancer Resource & Action Network acknowledged that this approach could enhance participation rates in screening programs.
Call for Enhanced Screening Measures
P.E.I. recently became the first Canadian province to lower screening age to 45, responding to growing advocacy for a more proactive approach. Colorectal Cancer Canada asserts that individuals under 50 are now two to two and a half times more likely to develop this form of cancer than in previous generations.
Research indicates that implementing a lower screening age could lead to over 15,000 fewer cases and about 6,100 deaths prevented over the next 45 years. While Ontario has taken similar steps, other provinces, including Nova Scotia and New Brunswick, are currently reviewing their guidelines.
Future Prospects for Screening in Canada
Advocates like Barry D. Stein from Colorectal Cancer Canada express hope that more provinces will adopt the new screening guidelines soon. Servidio-Italiano stressed the importance of ensuring blood-based tests can also detect precancerous conditions before widespread implementation.
As Canada considers adapting these recommendations, it is crucial that any new guidelines are based on solid evidence to ensure optimal health outcomes. The Canadian Cancer Society recommends biennial stool tests for those aged 45 to 74 who are not at high risk for colorectal cancer.
